search
Back to results

Study to Evaluate if Inhaled Nitric Oxide Improves Liver Function After Transplantation

Primary Purpose

Reperfusion Injury, Liver Injury

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
inhaled nitric oxide
nitrogen gas
Sponsored by
University of Alabama at Birmingham
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Reperfusion Injury focused on measuring ischemia-reperfusion, nitric oxide, inflammation, cell-death, Liver-function post transplantation

Eligibility Criteria

19 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients > 19 yr of age scheduled to undergo liver transplantation.

Exclusion Criteria:

  • Patients < 19 yr of age
  • Patients undergoing re-transplantation or dual organ transplantation
  • Patients with underlying pulmonary complications

Sites / Locations

  • University of Alabama at Birmingham
  • University of Washington

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

1. Experimental

2. Placebo

Arm Description

iNO administration

Placebo (nitrogen)

Outcomes

Primary Outcome Measures

Changed Rate of Liver Function Recovery Post-transplantation (Percent Change in AST Levels)
The faster the percent decrease of AST reflect the greater the treatment improved liver function post transplant. A positive percent reflects an decrease; a negative percentage reflects a increase. The rate was calculated by measuring AST levels at baseline and at 96 hours post baseline. (AST levels were lower at 96 hours relative to baseline- positive values in data table indicate percent decrease of AST relative to baseline).
Changed Rate of Liver Function Recovery Post-transplantation (Percent Change in ALT Levels)
The faster the percent decrease ALT reflect, the greater the treatment improved liver function post transplant. A positive percent reflects an decrease; a negative percentage reflects a increase. . (ALT levels were lower at 96 hours relative to baseline- positive values in data table indicate percent decrease of ALT relative to baseline).
Change in Rate of Liver Function Recovery Post-transplantation (Percent Change in Alkaline Phosphatase Levels)
The faster the percent increase of alkaline phosphatase reflect, the greater the treatment improved liver function post transplant. A positive percent reflects an increase; a negative percentage reflects a decrease.
Change in Rate of Liver Function Recovery Post-transplantation (Percent Change in Prothrombin Times (PT))
The faster the percent increase of PT reflect, the greater the treatment improved liver function post transplant. A positive percent reflects an decrease; a negative percentage reflects a increase.
Change in Rate of Liver Function Recovery Post-transplantation (Percent Change in Bilirubin Levels)
A positive percent reflects an decrease; a negative percentage reflects a increase.
Change in Rate of Liver Function Recovery Post-transplantation (Decrease in Hepatobiliary Complications)
Number of complications due to hepatobiliary events.
Number of Complications Related to Liver Function Recovery Post-transplantation (Total Complications) at 9 Months Post Surgery
Number of any complication reported by subjects at 9 months after surgery

Secondary Outcome Measures

Effect of iNO on Hosptial Length of Stay
number of days subject in hospital after surgery until discharge
Effect of iNO on SICU Stay
Number of minutes after surgery subject remained in SICU

Full Information

First Posted
December 20, 2007
Last Updated
November 5, 2014
Sponsor
University of Alabama at Birmingham
Collaborators
Mallinckrodt, University of Washington
search

1. Study Identification

Unique Protocol Identification Number
NCT00582010
Brief Title
Study to Evaluate if Inhaled Nitric Oxide Improves Liver Function After Transplantation
Official Title
Effects of Inhaled Nitric Oxide on Ischemia-Reperfusion Injury in Human Liver During Transplantation
Study Type
Interventional

2. Study Status

Record Verification Date
October 2014
Overall Recruitment Status
Completed
Study Start Date
April 2008 (undefined)
Primary Completion Date
March 2009 (Actual)
Study Completion Date
October 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Alabama at Birmingham
Collaborators
Mallinckrodt, University of Washington

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This blinded, placebo-controlled study will administer inhaled nitric oxide to patients undergoing liver transplantation. The purpose of the study is to test if inhaled nitric oxide prevents liver injury associated with the restoration of blood flow. The premise of the current study is provided by previous studies which document a protective effect of inhaled nitric oxide in this clinical setting.
Detailed Description
Specifically, presenting ischemia-reperfusion injury to transplanted livers remains a therapeutic goal in improving liver function and potentially expanding the number of transplantable livers. This study aims to assess the efficacy of inhaled nitric oxide to limit ischemia-reperfusion injury in transplanted livers and by doing so improve liver function post transplantation and decrease patient hospital length of stays.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Reperfusion Injury, Liver Injury
Keywords
ischemia-reperfusion, nitric oxide, inflammation, cell-death, Liver-function post transplantation

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
80 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1. Experimental
Arm Type
Experimental
Arm Description
iNO administration
Arm Title
2. Placebo
Arm Type
Placebo Comparator
Arm Description
Placebo (nitrogen)
Intervention Type
Drug
Intervention Name(s)
inhaled nitric oxide
Other Intervention Name(s)
iNO
Intervention Description
inhaled 80ppm for duration of surgery.
Intervention Type
Drug
Intervention Name(s)
nitrogen gas
Intervention Description
inhaled
Primary Outcome Measure Information:
Title
Changed Rate of Liver Function Recovery Post-transplantation (Percent Change in AST Levels)
Description
The faster the percent decrease of AST reflect the greater the treatment improved liver function post transplant. A positive percent reflects an decrease; a negative percentage reflects a increase. The rate was calculated by measuring AST levels at baseline and at 96 hours post baseline. (AST levels were lower at 96 hours relative to baseline- positive values in data table indicate percent decrease of AST relative to baseline).
Time Frame
baseline and 96 hours after baseline
Title
Changed Rate of Liver Function Recovery Post-transplantation (Percent Change in ALT Levels)
Description
The faster the percent decrease ALT reflect, the greater the treatment improved liver function post transplant. A positive percent reflects an decrease; a negative percentage reflects a increase. . (ALT levels were lower at 96 hours relative to baseline- positive values in data table indicate percent decrease of ALT relative to baseline).
Time Frame
baseline and 96 hours after baseline
Title
Change in Rate of Liver Function Recovery Post-transplantation (Percent Change in Alkaline Phosphatase Levels)
Description
The faster the percent increase of alkaline phosphatase reflect, the greater the treatment improved liver function post transplant. A positive percent reflects an increase; a negative percentage reflects a decrease.
Time Frame
baseline and 96 hours after baseline
Title
Change in Rate of Liver Function Recovery Post-transplantation (Percent Change in Prothrombin Times (PT))
Description
The faster the percent increase of PT reflect, the greater the treatment improved liver function post transplant. A positive percent reflects an decrease; a negative percentage reflects a increase.
Time Frame
baseline and 96 hours after baseline
Title
Change in Rate of Liver Function Recovery Post-transplantation (Percent Change in Bilirubin Levels)
Description
A positive percent reflects an decrease; a negative percentage reflects a increase.
Time Frame
baseline and 96 hours after baseline
Title
Change in Rate of Liver Function Recovery Post-transplantation (Decrease in Hepatobiliary Complications)
Description
Number of complications due to hepatobiliary events.
Time Frame
baseline to 9 months after transplantation
Title
Number of Complications Related to Liver Function Recovery Post-transplantation (Total Complications) at 9 Months Post Surgery
Description
Number of any complication reported by subjects at 9 months after surgery
Time Frame
baseline to 9 months post surgery
Secondary Outcome Measure Information:
Title
Effect of iNO on Hosptial Length of Stay
Description
number of days subject in hospital after surgery until discharge
Time Frame
from surgery through discharge from hospital
Title
Effect of iNO on SICU Stay
Description
Number of minutes after surgery subject remained in SICU
Time Frame
baseline to discharge for SICU

10. Eligibility

Sex
All
Minimum Age & Unit of Time
19 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients > 19 yr of age scheduled to undergo liver transplantation. Exclusion Criteria: Patients < 19 yr of age Patients undergoing re-transplantation or dual organ transplantation Patients with underlying pulmonary complications
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rakesh P Patel, PhD
Organizational Affiliation
University of Alabama at Birmingham
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Keith A Jones, MD
Organizational Affiliation
University of Alabama at Birmingham
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Devin E Eckhoff, MD
Organizational Affiliation
University of Alabama at Birmingham
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
John S Bynon, MD
Organizational Affiliation
University of Alabama at Birmingham
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Blair Smith, MD
Organizational Affiliation
University of Alabama at Birmingham
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Clark Cross, MD
Organizational Affiliation
University of Alabama at Birmingham
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Luc Frenette, MD
Organizational Affiliation
University of Alabama at Birmingham
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
John D Lang, MD
Organizational Affiliation
University of Washington
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Alabama at Birmingham
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35294
Country
United States
Facility Name
University of Washington
City
Seattle
State/Province
Washington
ZIP/Postal Code
98195-6540
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
17717604
Citation
Lang JD Jr, Teng X, Chumley P, Crawford JH, Isbell TS, Chacko BK, Liu Y, Jhala N, Crowe DR, Smith AB, Cross RC, Frenette L, Kelley EE, Wilhite DW, Hall CR, Page GP, Fallon MB, Bynon JS, Eckhoff DE, Patel RP. Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J Clin Invest. 2007 Sep;117(9):2583-91. doi: 10.1172/JCI31892.
Results Reference
background
PubMed Identifier
24533048
Citation
Lang JD Jr, Smith AB, Brandon A, Bradley KM, Liu Y, Li W, Crowe DR, Jhala NC, Cross RC, Frenette L, Martay K, Vater YL, Vitin AA, Dembo GA, Dubay DA, Bynon JS, Szychowski JM, Reyes JD, Halldorson JB, Rayhill SC, Dick AA, Bakthavatsalam R, Brandenberger J, Broeckel-Elrod JA, Sissons-Ross L, Jordan T, Chen LY, Siriussawakul A, Eckhoff DE, Patel RP. A randomized clinical trial testing the anti-inflammatory effects of preemptive inhaled nitric oxide in human liver transplantation. PLoS One. 2014 Feb 12;9(2):e86053. doi: 10.1371/journal.pone.0086053. eCollection 2014.
Results Reference
derived

Learn more about this trial

Study to Evaluate if Inhaled Nitric Oxide Improves Liver Function After Transplantation

We'll reach out to this number within 24 hrs